-
公开(公告)号:US20170328906A1
公开(公告)日:2017-11-16
申请号:US15527716
申请日:2015-07-29
Inventor: Eun Kyung CHOI , Seong-Yun JEONG , Si Yeol SONG , Kyoung Jin LEE , Jinhyang CHOI , Jaesook PARK , Seok Soon PARK , Jae Hee LEE
CPC classification number: G01N33/574 , A61K47/00 , A61K49/00 , A61K49/0004 , A61K49/0032 , A61K49/0056 , A61K51/08 , C07K7/06 , C07K14/00 , G01N33/00 , G01N33/57419 , G01N33/58
Abstract: Provided is a peptide for targeting colorectal cancer, a composition for diagnosing radioresponsiveness-dependent prognosis of colorectal cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, in consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.
-
公开(公告)号:US20190203302A1
公开(公告)日:2019-07-04
申请号:US16302092
申请日:2017-05-16
Inventor: Eun Kyung CHOI , Seong-Yun JEONG , Si Yeol SONG , Kyoung Jin LEE
IPC: C12Q1/6886 , G01N33/92
CPC classification number: C12Q1/6886 , A61K48/00 , C07K16/28 , C07K2317/34 , C12Q1/68 , C12Q2600/106 , G01N33/57419 , G01N33/92
Abstract: The present invention relates to a biomarker composition for diagnosing radiation-resistant cancer comprising LRP-1 as an active ingredient and a method of diagnosing radiation-resistant cancer using the same, and identifies LRP-1 which a binding partner protein to which specific peptide sequences specifically targeting radiation-resistant colon cancer tissues are actually bound, and based on this, suggests the possibility of radiation therapy resistance factor for cancer.
-
公开(公告)号:US20190018014A1
公开(公告)日:2019-01-17
申请号:US16149142
申请日:2018-10-02
Inventor: Eun Kyung CHOI , Seong-Yun JEONG , Si Yeol SONG , Kyoung Jin LEE , Seol Hwa SHIN , Eun Jin JU
Abstract: Provided is a peptide for targeting gastric cancer, a composition for diagnosing radioresponsiveness-dependent gastric cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.
-
-